General Information of the Compound
| Compound ID |
CP0538277
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(3S,4S)-1-cyclohexyl-3-[(1-pyridin-2-ylcyclopropyl)carbamoyl]piperidin-4-yl]-5-(2,4-difluorophenyl)-1,2-oxazole-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H33F2N5O3
|
||||||||||||||||||
| Molecular Weight |
549.622
|
||||||||||||||||||
| Canonical SMILES |
Fc1ccc(-c2cc(no2)C(=O)N[C@H]2CCN(C[C@@H]2C(=O)NC2(CC2)c2ccccn2)C2CCCCC2)c(F)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H33F2N5O3/c31-19-9-10-21(23(32)16-19)26-17-25(36-40-26)29(39)34-24-11-15-37(20-6-2-1-3-7-20)18-22(24)28(38)35-30(12-13-30)27-8-4-5-14-33-27/h4-5,8-10,14,16-17,20,22,24H,1-3,6-7,11-13,15,18H2,(H,34,39)(H,35,38)/t22-,24-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DOLXGWIZOQOXAE-UPVQGACJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04108, Atypical chemokine receptor 3
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2